Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025)
Elutia recorded quarterly Liabilities from Discontinued Operations of 134000.0 in Q3 2025, down 57.46% quarter-over-quarter from 315000.0 in Q4 2024.
Elutia's Liabilities from Discontinued Operations history runs 4 years deep, the most recent figure standing at 134000.0 for Q3 2025.
- In Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 134000.0; the TTM figure through Sep 2025 stood at 134000.0 (changed N/A YoY), while the FY2024 annual figure was 315000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at 134000.0 for Q3 2025 at Elutia, down from 315000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 4929000.0 in Q4 2022 to a low of 134000.0 in Q3 2025.
- A 4-year average of 1490750.0 and a median of 450000.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Dec 31, 2024 | 315,000.00 |
| Dec 31, 2024 | 315,000.00 |
| Sep 30, 2023 | 585,000.00 |
| Sep 30, 2023 | 585,000.00 |
| Dec 31, 2022 | 4.93 Mn |
| Dec 31, 2022 | 4.93 Mn |